BeiGene was among the first China-based biotech companies to list on Nasdaq and made history by raising $903 million in its secondary listing in Hong Kong. Now, it’s ready to pull a hat trick as it …
( read original story …)
The Shanghai News
BeiGene was among the first China-based biotech companies to list on Nasdaq and made history by raising $903 million in its secondary listing in Hong Kong. Now, it’s ready to pull a hat trick as it …
( read original story …)